GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guiyang Xintian Pharmaceutical Co 002873.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

7.40

-1.99%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Guiyang Xintian Pharmaceutical Co

Its shares trade on Shenzhen under the ticker 002873.SZ. It has been listed since 19 May 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥749.7m and net income of CN¥9.1m. At that date it held total assets of CN¥2.12bn and shareholders' equity of CN¥1.26bn.

Guiyang Xintian Pharmaceutical Co., Ltd. engages in the production, sale, research and development of Chinese medicines. The company is headquartered in Guiyang, Guizhou. The company went IPO on 2017-05-19. The firm manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
19 May 2017
Employees
929
Website
gyxtyy.com ↗

Leadership

Pay as last reported

  • Mr. Dalun DongChairman of the Board, General Manager, since 2005
  • Mr. Jinhua WangVice Chairman of the Board, Deputy General Manager, since 2022
  • Ms. Zhihui ZengChief Financial Officer
  • Mr. Guangping WangDeputy General Manager, Secretary of the Board , Director, since 2017
  • Mr. Maochen WeiDeputy General Manager
  • Mr. Zhonglei HeStaff Elected Director
  • Ms. Weijia JiDirector
  • Mr. Wenyi WangDirector
  • Mr. Lijin GaoIndependent Director
  • Mr. Feng GuanIndependent Director
  • Ms. Jie ZhangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Guiyang Xintian Pharmaceutical employs 929 full-time employees in the Health Care sector.
  • Ningmitai Capsule and Kuntai Capsule are key products in the domestic market.
  • The company manufactures capsules, syrups, and gel products for Chinese medicine.

Weaknesses

  • The company distributes products only in the domestic market within China.
  • Guiyang Xintian Pharmaceutical has no international presence or global expansion.
  • The firm's IPO was in 2017, indicating limited recent market activity.

Opportunities

  • Expanding into international markets could leverage Chinese medicine demand.
  • Growing domestic demand for Chinese medicine products presents opportunities.
  • Research and development in pharmaceuticals may lead to new product lines.

Threats

  • Competition from other Chinese pharmaceutical companies in the domestic market.
  • Regulatory changes in the Chinese Health Care sector could impact operations.
  • Economic downturns in China may reduce consumer spending on medicines.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.